Class of 2020A

The Ebola outbreak in West Africa is the world's deadliest to date and the World Health Organization has declared an international health emergency as more than 3,850 people have died of the virus in Guinea, Liberia, Sierra Leone and Nigeria this year.

If you travel to or are in an area affected by an Ebola outbreak, make sure to do the following:Practice careful hygiene. For example, wash your hands with soap and water or an alcohol-based hand sanitizer and avoid contact with blood and body fluids.Do not handle items that may have come in contact with an infected person’s blood or body fluids (such as clothes, bedding, needles, and medical equipment).Avoid funeral or burial rituals that require handling the body of someone who has died from Ebola.Avoid contact with bats and nonhuman primates or blood, fluids, and raw meat prepared from these animals.Avoid hospitals in West Africa where Ebola patients are being treated. The U.S. embassy or consulate is often able to provide advice on facilities.After you return, monitor your health for 21 days and seek medical care immediately if you develop symptoms of Ebola(http://www.cdc.gov/vhf/ebola/symptoms/index.html).

People who recover from infection with Ebola virus produce antibodies that last at least 10 years.

With tuberculosis, you must take antibiotics for at least six to nine months. The exact drugs and length of treatment depend on your age, overall health, possible drug resistance, the form of TB (latent or active) and the infection's location in the body.

Most common TB drugs If you have latent tuberculosis, you may need to take just one type of TB drug. Active tuberculosis, particularly if it's a drug-resistant strain, will require several drugs at once. The most common medications used to treat tuberculosis include: Isoniazid Rifampin (Rifadin, Rimactane) Ethambutol (Myambutol) Pyrazinamide If you have drug-resistant TB, a combination of antibiotics called fluoroquinolones and injectable medications, such as amikacin, kanamycin or capreomycin, are generally used for 20 to 30 months. Some types of TB are developing resistance to these medications as well. A number of new drugs are being looked at as add-on therapy to the current drug-resistant combination treatment including: Bedaquiline Delamanid PA-824 Linezolid Sutezolid